GlassScriptPhysician profile
John A Lucas
NPI 1659692952
$1,396.83
in general payments reported to CMS, 2019-2025
10 companies · $280 in 2025
The $280 reported for 2025 was more than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $217 · 2021: $187 · 2022: $131 · 2023: $225 · 2024: $82.94 · 2025: $280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $404.07 | 2019-2020 | |
| Horizon Therapeutics Plc | $233.81 | 2019-2022 | |
| Bioventus LLC | $221.46 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System, Durolane |
| Ferring Pharmaceuticals INC. | $178.53 | 2022-2025 | Euflexxa |
| Zimmer Biomet Holdings, INC. | $138.61 | 2023 | Mymobility Platform |
| Depuy Synthes Sales INC. | $101.06 | 2024-2025 | Monovisc, Orthovisc |
| Stryker Corporation | $40.91 | 2021 | |
| Peerless Surgical INC. | $31.94 | 2022 | |
| Ethicon US, LLC | $29.12 | 2021 | |
| Abbott Laboratories | $17.32 | 2023 | Penta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lucas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.